Schlenk, R. F., Weber, D., Herr, W., Wulf, G., Salih, H. R., Derigs, H. G., . . . Döhner, H. (2019). Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine. Leukemia, 33(8), . https://doi.org/10.1038/s41375-019-0395-y
Chicago-Zitierstil (17. Ausg.)Schlenk, Richard Friedrich, et al. "Randomized Phase-II Trial Evaluating Induction Therapy with Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy with Azacitidine." Leukemia 33, no. 8 (2019). https://doi.org/10.1038/s41375-019-0395-y.
MLA-Zitierstil (9. Ausg.)Schlenk, Richard Friedrich, et al. "Randomized Phase-II Trial Evaluating Induction Therapy with Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy with Azacitidine." Leukemia, vol. 33, no. 8, 2019, https://doi.org/10.1038/s41375-019-0395-y.